Long Xue

Title: Long Xue: Innovator in Pharmaceutical Compounds

Introduction

Long Xue is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as protein kinase inhibitors. His work is essential in addressing diseases related to abnormal protein kinase activities.

Latest Patents

Long Xue holds 1 patent for his invention titled "Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinases inhibitor." This invention introduces a new class of dihydroindene amide compounds, which can be utilized in pharmaceutical compositions to inhibit protein kinases. The compounds are particularly effective in preventing or curing diseases associated with the abnormal activities of protein kinases, such as Abl, Bcr-Abl, c-Kit, and PDGFR.

Career Highlights

Long Xue is currently associated with Harbin Gloria Pharmaceuticals Co., Ltd. His role in the company has allowed him to focus on innovative research and development in the pharmaceutical sector. His expertise in creating effective pharmaceutical compositions has positioned him as a valuable asset in the industry.

Collaborations

Long Xue has collaborated with notable colleagues, including Xuqing Yang and Juan Luo. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Long Xue's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in medical treatments and therapies.